Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation

Medicine & Life Sciences

• 2,2-bis(4-glycidyloxyphenyl)propane 27%
• 2,4-thiazolidinedione 11%
• 3-nitrotyrosine 10%
• Animal Models 5%
• Anti-Inflammatory Agents 11%
• Carrageenan 46%
• Cell Proliferation 5%
• Cyclooxygenase 2 8%
• Cytoplasmic and Nuclear Receptors 8%
• Edema 19%
• Exudates and Transudates 8%
• Immunohistochemistry 5%
• Inflammation 46%
• Injections 4%
• Intercellular Adhesion Molecule-1 8%
• Ligands 55%
• Lung 4%
• Nitric Oxide Synthase Type II 8%
• P-Selectin 9%
• Peroxisome Proliferator-Activated Receptors 94%
• Pleurisy 20%
• Poly(ADP-ribose) Polymerases 9%
• Retinoids 8%
• Rosiglitazone 100%
• Staining and Labeling 5%
• Steroids 5%
• Therapeutics 3%
• Thyroid Hormone Receptors 10%
• Transcription Factors 5%
• Type 2 Diabetes Mellitus 5%
• United States Food and Drug Administration 7%
• Wounds and Injuries 3%